當(dāng)前位置：首頁(yè) SCI期刊 SCIE期刊 JCRQ3 期刊介紹(非官網(wǎng))

Neuropsychopharmacology ReportsSCIE

國(guó)際簡(jiǎn)稱(chēng)：Neuropsychopharmacology Reports 參考譯名：神經(jīng)精神藥理學(xué)報(bào)告

CiteScore分區(qū)
Q2
JCR分區(qū)
Q3

基本信息：: ISSN：2574-173X; 是否OA：開(kāi)放; 是否預(yù)警：否

出版信息：: 出版地區(qū)：Australia; 出版商：Wiley-Blackwell; 出版語(yǔ)言：English; 研究方向：Psychology-Clinical Psychology

評(píng)價(jià)信息：: 影響因子：2; CiteScore指數(shù)：3.6; SJR指數(shù)：0.66; SNIP指數(shù)：0.65

發(fā)文數(shù)據(jù)：: Gold OA文章占比：74.37%; 研究類(lèi)文章占比：91.49%; 年發(fā)文量：94

投稿咨詢(xún) 加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Neuropsychopharmacology Reports期刊介紹

Neuropsychopharmacology Reports is a peer-reviewed open access journal focused on the field of neuropsychological pharmacology. This journal aims to rapidly disseminate research findings on neurological function, psychiatry, drug mechanisms of action, and new drug development. The content of the journal covers a wide range of research from basic science to clinical trials, providing an important knowledge exchange platform for researchers, clinical doctors, and other healthcare professionals.

The main readership of this magazine includes neuroscientists, psychiatrists, pharmacologists, clinical doctors, graduate students, and postdoctoral researchers. One of its characteristics is its fast publishing model, which helps researchers quickly share their findings and drive scientific progress in the field. In addition, the journal emphasizes the clinical relevance of research and encourages submission of studies that can directly impact patient care and treatment. Through an open access publishing model, this journal ensures wide accessibility of research findings, promotes scientific collaboration and knowledge dissemination on a global scale.

期刊簡(jiǎn)介Neuropsychopharmacology Reports期刊介紹

《Neuropsychopharmacology Reports》該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間： 14 Weeks
SCIE
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Neuropsychopharmacology Reports Cite Score數(shù)據(jù)

CiteScore：3.6
SJR：0.66
SNIP：0.646

學(xué)科類(lèi)別	分區(qū)	排名	百分位
大類(lèi)：Psychology 小類(lèi)：Clinical Psychology	Q2	121 / 311	61%
大類(lèi)：Psychology 小類(lèi)：Psychiatry and Mental Health	Q2	274 / 567	51%
大類(lèi)：Psychology 小類(lèi)：Pharmacology (medical)	Q3	142 / 272	47%
大類(lèi)：Psychology 小類(lèi)：Pharmacology	Q3	188 / 313	40%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

JCR分區(qū)Neuropsychopharmacology Reports JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：NEUROSCIENCES	ESCI	Q3	228 / 310	26.6%
學(xué)科：PHARMACOLOGY & PHARMACY	ESCI	Q3	222 / 354	37.4%
學(xué)科：PSYCHIATRY	ESCI	Q3	157 / 276	43.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：NEUROSCIENCES	ESCI	Q4	236 / 310	24.03%
學(xué)科：PHARMACOLOGY & PHARMACY	ESCI	Q3	225 / 354	36.58%
學(xué)科：PSYCHIATRY	ESCI	Q3	176 / 276	36.41%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門(mén)類(lèi)和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders
Author: Fukumoto, Kentaro; Kodaka, Fumitoshi; Hasegawa, Naomi; Muraoka, Hiroyuki; Hori, Hikaru; Ichihashi, Kayo; Yasuda, Yuka; Iida, Hitoshi; Ohi, Kazutaka; Ochi, Shinichiro; Ide, Kenta; Hashimoto, Naoki; Usami, Masahide; Nakamura, Toshinori; Komatsu, Hiroshi; Okada, Tsuyoshi; Nagasawa, Tatsuya; Furihata, Ryuji; Atake, Kiyokazu; Kido, Mikio; Kikuchi, Saya; Yamagata, Hirotaka; Kishimoto, Taishiro; Makinodan, Manabu; Horai, Tadasu; Takeshima, Masahiro; Kubota, Chika; Asami, Takeshi; Katsumoto, Eiichi; Hishimoto, Akitoyo; Onitsuka, Toshiaki; Matsumoto, Junya; Miura, Kenichiro; Yamada, Hisashi; Yasui-Furukori, Norio; Watanabe, Koichiro; Inada, Ken; Otsuka, Kotaro; Hashimoto, Ryota

Journal: NEUROPSYCHOPHARMACOLOGY REPORTS. 2023; Vol. 43, Issue 1, pp. 33-39. DOI: 10.1002/npr2.12301
2、Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
Author: Iida, Hitoshi; Okada, Tsuyoshi; Nemoto, Kiyotaka; Hasegawa, Naomi; Numata, Shusuke; Ogasawara, Kazuyoshi; Miura, Kenichiro; Matsumoto, Junya; Hori, Hikaru; Iga, Jun-ichi; Ichihashi, Kayo; Hashimoto, Naoki; Yamada, Hisashi; Ohi, Kazutaka; Yasui-Furukori, Norio; Fukumoto, Kentaro; Tsuboi, Takashi; Usami, Masahide; Furihata, Ryuji; Takaesu, Yoshikazu; Hishimoto, Akitoyo; Muraoka, Hiroyuki; Katsumoto, Eiichi; Nagasawa, Tatsuya; Ochi, Shinichiro; Komatsu, Hiroshi; Kikuchi, Saya; Takeshima, Masahiro; Onitsuka, Toshiaki; Tamai, Shinichiro; Kubota, Chika; Inada, Ken; Watanabe, Koichiro; Kawasaki, Hiroaki; Hashimoto, Ryota

Journal: NEUROPSYCHOPHARMACOLOGY REPORTS. 2023; Vol. 43, Issue 1, pp. 23-32. DOI: 10.1002/npr2.12300